Related Experiment Videos
Epidural narcotic analgesia after thoracotomy
J J Pelton1, D J Fish, S M Keller
1Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pa.
Southern Medical Journal
|October 1, 1993
Summary
Epidural narcotic analgesia (ENA) is safe and effective for thoracic surgery patients, significantly reducing the need for postoperative intravenous narcotics and offering comparable extubation outcomes.
Area of Science:
- Anesthesiology
- Thoracic Surgery
- Pain Management
Background:
- Epidural narcotic analgesia (ENA) benefits are known in general surgery.
- Thoracic surgery presents unique challenges for pain management and respiratory support.
Purpose of the Study:
- To evaluate the safety and effectiveness of ENA in patients undergoing thoracotomy.
- To investigate potential interactions between ENA and intraoperative intravenous narcotics (IIN).
Main Methods:
- Retrospective review of 130 consecutive thoracotomy patients.
- Comparison of postoperative intravenous morphine sulfate requirements between ENA and non-ENA groups.
- Analysis of extubation timing and postoperative PCO2 levels.
Main Results:
- Patients receiving ENA required significantly less postoperative intravenous morphine sulfate (0.19 mg/kg vs. 0.44 mg/kg).
- Extubation timing and immediate postoperative PCO2 levels were similar between groups.
- No technical complications or reintubations were reported within 72 hours for ENA patients.
Conclusions:
- ENA is a safe and valuable analgesic option for patients after thoracotomy.
- ENA effectively reduces the requirement for postoperative intravenous narcotics.
- Concomitant IIN did not significantly alter PCO2 but may influence extubation timing at higher doses.